DK2991633T3 - Bakteriofagterapi - Google Patents

Bakteriofagterapi Download PDF

Info

Publication number
DK2991633T3
DK2991633T3 DK14724663.1T DK14724663T DK2991633T3 DK 2991633 T3 DK2991633 T3 DK 2991633T3 DK 14724663 T DK14724663 T DK 14724663T DK 2991633 T3 DK2991633 T3 DK 2991633T3
Authority
DK
Denmark
Prior art keywords
bacteriophage
Prior art date
Application number
DK14724663.1T
Other languages
English (en)
Inventor
Pascal Danglas
Laurent Debarbieux
Original Assignee
Ferring Bv
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv, Pasteur Institut filed Critical Ferring Bv
Application granted granted Critical
Publication of DK2991633T3 publication Critical patent/DK2991633T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10111Myoviridae
    • C12N2795/10132Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10111Myoviridae
    • C12N2795/10171Demonstrated in vivo effect
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK14724663.1T 2013-04-30 2014-04-30 Bakteriofagterapi DK2991633T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13305568.1A EP2799063A1 (en) 2013-04-30 2013-04-30 Bacteriophage therapy
PCT/EP2014/058840 WO2014177622A1 (en) 2013-04-30 2014-04-30 Bacteriophage therapy

Publications (1)

Publication Number Publication Date
DK2991633T3 true DK2991633T3 (da) 2019-07-29

Family

ID=48485088

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14724663.1T DK2991633T3 (da) 2013-04-30 2014-04-30 Bakteriofagterapi
DK19172749.4T DK3563837T5 (da) 2013-04-30 2014-04-30 Bakteriofagterapi

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19172749.4T DK3563837T5 (da) 2013-04-30 2014-04-30 Bakteriofagterapi

Country Status (29)

Country Link
US (3) US11040078B2 (da)
EP (3) EP2799063A1 (da)
JP (1) JP6543615B2 (da)
KR (1) KR102215453B1 (da)
CN (1) CN105407872B (da)
AU (1) AU2014261461B2 (da)
BR (1) BR112015027269B1 (da)
CA (1) CA2910539C (da)
DK (2) DK2991633T3 (da)
EA (1) EA034195B1 (da)
ES (2) ES2902599T3 (da)
HK (1) HK1221164A1 (da)
HR (2) HRP20211860T2 (da)
HU (2) HUE056968T2 (da)
IL (1) IL242293B (da)
LT (2) LT3563837T (da)
MX (1) MX366497B (da)
MY (1) MY186607A (da)
NZ (1) NZ713423A (da)
PH (1) PH12015502500B1 (da)
PL (2) PL2991633T3 (da)
PT (2) PT3563837T (da)
RS (2) RS62644B9 (da)
SA (1) SA515370073B1 (da)
SG (1) SG11201508897QA (da)
SI (2) SI2991633T1 (da)
TR (1) TR201910955T4 (da)
WO (1) WO2014177622A1 (da)
ZA (1) ZA201508212B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2799063A1 (en) 2013-04-30 2014-11-05 Ferring B.V. Bacteriophage therapy
EP3595689A4 (en) * 2017-03-14 2020-12-09 Brigham Young University METHODS AND COMPOSITIONS FOR TREATING OBESITY, INFLAMMATION OR METABOLIC DISORDERS WITH BACTERIOPHAGES
US20220031776A1 (en) * 2017-09-08 2022-02-03 Keio University Bacteriophage for modulating inflammatory bowel disease
US11986502B2 (en) 2018-05-23 2024-05-21 Optium, LLC Bacteriophage compositions and kits and related methods
EP3796781A4 (en) * 2018-05-23 2022-04-20 Brigham Young University BACTERIOPHAGE COMPOSITIONS, AND KITS AND RELATED METHODS
US20230068309A1 (en) * 2019-12-23 2023-03-02 Entasis Therapeutics, Inc. Managing microbial dysbiosis with temocillin
US20220323518A1 (en) * 2021-04-10 2022-10-13 Intron Biotechnology, Inc. Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis
US20220331381A1 (en) * 2021-04-10 2022-10-20 Intron Biotechnology, Inc. Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis
US20220323517A1 (en) * 2021-04-10 2022-10-13 Intron Biotechnology, Inc. Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis
IL307852A (en) 2021-04-22 2023-12-01 Ferring Bv Treatment with bacteriophages against adherent-invasive ESCHERICHIA COLI

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020013270A1 (en) * 2000-06-05 2002-01-31 Bolte Ellen R. Method for treating a mental disorder
GB0019721D0 (en) * 2000-08-10 2000-09-27 Regma Biotechnologies Ltd Novel method
EP2377883A1 (en) * 2010-04-15 2011-10-19 Universite d'Auvergne Clermont I Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease
EP3789031B1 (en) * 2010-09-17 2023-08-02 Technophage, Investigação e Desenvolvimento em Biotecnologia, SA Antibacterial phage, phage peptides and methods of use thereof
WO2013045863A1 (fr) 2011-09-29 2013-04-04 Institut Pasteur Detection de souches e.coli de serotype o104
EP2799063A1 (en) 2013-04-30 2014-11-05 Ferring B.V. Bacteriophage therapy

Also Published As

Publication number Publication date
KR20160005728A (ko) 2016-01-15
NZ713423A (en) 2020-07-31
EP3563837B9 (en) 2022-02-16
MX366497B (es) 2019-07-11
RS62644B9 (sr) 2022-04-29
US20160143965A1 (en) 2016-05-26
HUE056968T2 (hu) 2022-04-28
LT2991633T (lt) 2019-07-25
IL242293B (en) 2019-09-26
PL2991633T3 (pl) 2019-10-31
PT3563837T (pt) 2021-12-03
EP3563837A1 (en) 2019-11-06
MX2015015092A (es) 2016-06-07
EP2991633A1 (en) 2016-03-09
EP2799063A1 (en) 2014-11-05
SG11201508897QA (en) 2015-11-27
SI2991633T1 (sl) 2019-09-30
LT3563837T (lt) 2021-12-27
MY186607A (en) 2021-07-30
HK1221164A1 (zh) 2017-05-26
CN105407872B (zh) 2020-06-12
AU2014261461A1 (en) 2015-11-12
CA2910539C (en) 2022-05-17
EA201591979A1 (ru) 2016-04-29
CN105407872A (zh) 2016-03-16
US11040078B2 (en) 2021-06-22
SA515370073B1 (ar) 2018-02-12
EP3563837B1 (en) 2021-10-20
US20240342230A1 (en) 2024-10-17
RS62644B1 (sr) 2021-12-31
PH12015502500A1 (en) 2016-02-22
PH12015502500B1 (en) 2016-02-22
RS59046B1 (sr) 2019-08-30
JP6543615B2 (ja) 2019-07-10
TR201910955T4 (tr) 2019-08-21
HRP20191363T1 (hr) 2019-11-01
DK3563837T3 (da) 2021-12-06
HRP20211860T1 (hr) 2022-03-04
EP2991633B1 (en) 2019-06-19
KR102215453B1 (ko) 2021-02-15
ZA201508212B (en) 2022-03-30
BR112015027269A2 (pt) 2017-09-26
PT2991633T (pt) 2019-08-07
WO2014177622A1 (en) 2014-11-06
ES2902599T3 (es) 2022-03-29
US20210386805A1 (en) 2021-12-16
DK3563837T5 (da) 2022-03-21
EA034195B1 (ru) 2020-01-16
SI3563837T1 (sl) 2022-04-29
HUE044431T2 (hu) 2019-10-28
BR112015027269B1 (pt) 2023-04-25
CA2910539A1 (en) 2014-11-06
US11918613B2 (en) 2024-03-05
HRP20211860T2 (hr) 2022-03-18
JP2016519126A (ja) 2016-06-30
ES2740124T3 (es) 2020-02-05
PL3563837T3 (pl) 2022-02-07
AU2014261461B2 (en) 2019-04-18

Similar Documents

Publication Publication Date Title
FIC20230030I1 (fi) mirikitsumabi
DK3342773T3 (da) Syk-hæmmere
DK3613453T3 (da) Fordamper
DK3077047T3 (da) Aramcholsalte
DK2991633T3 (da) Bakteriofagterapi
DK3060460T3 (da) Saddel
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
DK2956698T5 (da) Bindestrimler
DK3052081T3 (da) Pastil
DK2946640T3 (da) Langmuir-probe
DE102013106534B8 (de) Chromatographiepipettenspitze
DK3071227T3 (da) Fiskevaccine
DE112014001252A5 (de) Aufbissschiene
FI20135542A (fi) Rumpusuodinlaite
DK2981168T3 (da) Laminitiskile
DK3086679T3 (da) Sportssko
FI10639U1 (fi) Uppoporauslaitteisto
FI10138U1 (fi) Kelkkateltta
ES1078715Y (es) Mosquitera
FI10779U1 (fi) Energiapuukoura
DE112014005422A5 (de) Friktionsfalschdrallaggregat
BR112016000501A2 (pt) Nalador
FI10481U1 (fi) Polanneterä
ES1100380Y (es) Trompo
ES1093505Y (es) Aerociclo